Analysts Offer Insights on Healthcare Companies: Polynovo (OtherCALZF), Clinuvel Pharmaceuticals (OtherCLVLF) and Impedimed Limited (OtherIPDQF)
Bell Potter upgrades Polynovo (CALZF) to a Buy
Morgans Sticks to Their Buy Rating for Polynovo (CALZF)
Macquarie Keeps Their Buy Rating on Polynovo (CALZF)
PNV: Sales up 16.7% to A$138.4m, with EBITDA up 50.4% and strong global expansion